Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept

類似資料

• Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis
  著者:: Hebeisen, Monika, 等
  出版事項: (2019)
• Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits
  著者:: Rekaya, Naceur, 等
  出版事項: (2020)
• Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
  著者:: Martínez-Pérez, Rosalía, 等
  出版事項: (2011)
• Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
  著者:: Ellis, Lorie A, 等
  出版事項: (2019)
• Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
  著者:: Martínez-Pérez, Rosalía, 等
  出版事項: (2012)